MYONIQ Evidence-Aligned Formulation Decision Framework
Framework Version & Status
MYONIQ Evidence-Aligned Formulation Decision Framework
Version: v1.0
Published: November 2025
Status: Actively applied across MYONIQ Nutrition product development processes
MYONIQ LLC develops wellness and performance products using a structured formulation decision framework designed to align ingredient selection, dosing, and functional intent with published scientific evidence and real-world application.
This framework was developed to address a recurring industry problem: products that reference scientifically studied ingredients without providing sufficient transparency or dosing clarity to allow objective evaluation by practitioners, retailers, or consumers.
Rather than focusing on individual products, the MYONIQ framework establishes a repeatable decision system for formulation design and evaluation that can be applied consistently across product categories and use cases.
Purpose of the Framework
The purpose of the MYONIQ Evidence-Aligned Formulation Decision Framework is to:
- Enable objective evaluation of performance and wellness formulations
- Align ingredient dosing with ranges supported by published research
- Define the functional role of each ingredient within a formulation
- Reduce ambiguity created by opaque labeling practices
- Support consistent formulation logic across current and future products
Core Framework Principles
1. Full Ingredient Disclosure
All active ingredients are listed individually with exact quantities.
Ingredients are not grouped under proprietary or composite blends.
This allows third parties to:
- Compare formulations objectively
- Assess research alignment
- Replicate or critique dosing logic
2. Evidence-Aligned Dosing Logic
Ingredient quantities are selected based on:
- Peer-reviewed literature
- Established dosage ranges used in clinical or applied research
- Safety and tolerance considerations
Where evidence varies, conservative and clearly documented ranges are used rather than maximal or ambiguous dosing.
3. Defined Functional Roles
Each ingredient included in a formulation must serve a specific physiological or functional purpose, such as:
- Hydration and electrolyte balance
- Energy metabolism
- Cognitive performance
- Recovery and fatigue management
Ingredients are not included for label density, marketing aesthetics, or trend alignment.
4. Structural Transparency
The framework emphasizes structural clarity over claims.
Products are designed so that the formulation logic can be understood without reliance on marketing language or performance promises.
This allows practitioners to evaluate products based on:
- Structure
- Inputs
- Intended function
Rather than subjective outcome claims.
5. Manufacturing Context Disclosure
Formulations developed under this framework are manufactured in:
- FDA-registered facilities
- GMP-certified environments
Manufacturing context is treated as a required disclosure component, not an implied standard.
Framework Decision Logic
(Public Overview)
The MYONIQ Evidence-Aligned Formulation Decision Framework follows a structured decision logic to ensure consistency, scientific alignment, and exclusion of non-functional ingredients.
Step 1
Evidence Availability Review
Each ingredient is evaluated for credible scientific evidence supporting its intended physiological role.
- Ingredients lacking reproducible evidence are excluded.
- Ingredients with supporting evidence proceed to dosage evaluation.
Step 2
Dosage Range Identification
Available research is reviewed to identify documented effective dosage ranges.
- When a clear range exists, formulation targets remain within that range.
- When consensus is limited, conservative and well-documented lower-bound dosing is applied.
Step 3
Functional Role Validation
Each ingredient must serve a defined, non-redundant functional purpose within the formulation. Ingredients included primarily for marketing appeal, trend alignment, or label perception are excluded.
Step 4
Interaction and Redundancy Review
Ingredients are reviewed for:
- Functional overlap
- Counterproductive interactions
- Unnecessary complexity
Redundant or conflicting ingredients are removed to preserve structural clarity.
Step 5
Transparency Confirmation
Final formulations must disclose exact ingredient quantities. Proprietary blends or undisclosed dosing structures are not permitted under this framework.
Ingredient Exclusion Criteria
Ingredients are excluded during formulation review if any of the following conditions apply:
- No credible scientific evidence supporting the claimed physiological function
- Required effective dosage exceeds safe or practical formulation limits
- Inclusion is primarily marketing-driven rather than function-driven
- Functional redundancy with existing ingredients
- Inability to disclose exact ingredient quantities
Ingredients meeting any exclusion criterion are removed prior to formulation finalization.
Application of the Framework
The MYONIQ Evidence-Aligned Formulation Decision Framework is currently applied across MYONIQ Nutrition’s performance-focused product lineup.
The same framework is designed to be extended to future categories, including:
- Functional nutrition systems
- Recovery-focused formulations
- Wellness technology integrations
Practical Use by Practitioners
The framework is designed to be usable by third parties, including:
- Personal trainers
- Nutrition professionals
- Performance practitioners
- Retail buyers
By emphasizing transparency and structure, the framework enables practitioners to integrate products into structured programs without relying on unverifiable assumptions.
Framework Development
The MYONIQ Evidence-Aligned Formulation Decision Framework was developed through founder-led research, applied evaluation of existing market formulations, and synthesis of published scientific literature.
The framework prioritizes repeatability, clarity, and disciplined execution over rapid product expansion.
ABOUT
MYONIQ
MYONIQ LLC is a U.S.-based wellness company structured as a multi-division organization focused on building evidence-aligned systems across nutrition, recovery, and health-focused platforms.
MYONIQ Nutrition operates as the company’s flagship consumer brand and serves as the initial implementation layer for the framework described above.